An additional meningioma (case #43) harbored an inactivating truncating mutation in CDKN2A (p.A60fs) with loss of the remaining wildtype allele which also demonstrated complete absence of p16 expression (Supplementary Fig. 1 [Online Resource 2]). The gene discussed is CDKN2A; the disease is meningioma.